Products for Research Use Only
RegisterLogin

Suciraslimab

CAT: 0804-HY-P990781-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990781-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Suciraslimab (SM03) is an anti-human CD22 monoclonal antibody. Suciraslimab inhibits NLRP3 and ASC signaling. Suciraslimab suppresses cytokine (IL-1β, IL-12, IL-23) secretion and α4 integrin expression. Suciraslimab improves working memory and neuroinflammation[1]. Suciraslimab isotype control product: Human IgG1 kappa, Isotype Control.
CAS Number
2415439-63-1
Product Name Alternative
SM03
UNSPSC
12352203
Target
CD22; Integrin; Interleukin Related; NOD-like Receptor (NLR)
Type
Inhibitory Antibodies
Related Pathways
Cytoskeleton; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/suciraslimab.html
Purity
97.42
Smiles
[Suciraslimab]
Molecular Weight
(146.16 kDa)
References & Citations
[1]Mai YD, et al. CD22 modulation alleviates amyloid β-induced neuroinflammation. J Neuroinflammation. 2025 Feb 5;22 (1) :32.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
IL-1; IL-12; IL-23

Alternative Products

CatalogName
abx831858-01Suciraslimab
GTR18612661-01Suciraslimab Antibody
WA3575Research Grade Suciraslimab
E55B0898Suciraslimab (Reference antibody)
A138568Suciraslimab Biosimilar (Monoclonal, IgG1)
ICH5884-5mgSuciraslimab Biosimilar - Research Grade
GTR18780755-01(Suciraslimab) Biosimilar Reference Antibody
GTR18697200-01Suciraslimab Human Monoclonal Antibody
12-90322-100Anti-CD22 (suciraslimab biosimilar) mAb
RA0682-01Suciraslimab (Biosimilar Reference Antibody) (SIGLEC2)

Popular Products